Simran Malik
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
-
- Neuroendocrine Tumor Research Advances
Papers in
-
- Cancer therapeutics and mechanisms 3
- Biochemical and Molecular Research 2
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Lung Cancer Research Studies 2
- Co-authors
- Richard J. Osborne (1 shared paper)R H Reznek (1 shared paper)Peter Clark (1 shared paper)Donna Lowe (1 shared paper)P. F. M. Wrigley (1 shared paper)M L Slevin (1 shared paper)W. Gregory (1 shared paper)John L. Marshall (4 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Redox Biology (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Human Vaccines & Immunotherapeutics (1 paper)Indian Journal of Medical Microbiology (1 paper)
- Partner nations
- United StatesIndiaItaly
In The Last Decade
Simran Malik
14 papers receiving 474 citations
Peers
Comparison fields: 5 of 60
- Oncology 315
- Epidemiology 144
- Molecular Biology 188
- Geriatrics and Gerontology 7
- Pulmonary and Respiratory Medicine 65
Countries citing papers authored by Simran Malik
This map shows the geographic impact of Simran Malik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simran Malik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simran Malik more than expected).
Fields of papers citing papers by Simran Malik
This network shows the impact of papers produced by Simran Malik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simran Malik. The network helps show where Simran Malik may publish in the future.
Co-authors
The 25 scholars most cited alongside Simran Malik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 408 | |
| 2 | 2007 | 12 | |
| 3 | 2020 | 11 | |
| 4 | 2024 | 11 | |
| 5 | 2008 | 11 | |
| 6 | 2005 | 11 | |
| 7 | 2009 | 9 | |
| 8 | 2022 | 9 | |
| 9 | 2006 | 6 | |
| 10 | 2024 | 3 | |
| 11 | 2010 | 3 | |
| 12 | 2008 | 2 | |
| 13 | 2005 | 1 | |
| 14 | 2005 | 1 |
About Simran Malik
Simran Malik is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Pharmacology, having authored 14 papers that have together received 498 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Research Studies (2 papers), Biochemical and Molecular Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Oncology (315 citations), Epidemiology (144 citations), Molecular Biology (188 citations), Geriatrics and Gerontology (7 citations) and Pulmonary and Respiratory Medicine (65 citations). Simran Malik has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Richard J. Osborne, R H Reznek, Peter Clark, Donna Lowe, P. F. M. Wrigley, M L Slevin, W. Gregory, John L. Marshall, Tila Khan and Sonya L. Heath. Their work appears in journals such as Journal of Clinical Oncology, Redox Biology, JAIDS Journal of Acquired Immune Deficiency Syndromes, Human Vaccines & Immunotherapeutics and Indian Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.